| Year |
Citation |
Score |
| 2016 |
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower MC, Govindan R, Hennon M, Horn L, Jahan TM, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. Journal of the National Comprehensive Cancer Network : Jnccn. 14: 255-64. PMID 26957612 DOI: 10.6004/Jnccn.2016.0031 |
0.317 |
|
| 2013 |
Rudin CM, Brahmer JR, Juergens RA, Hann CL, Ettinger DS, Sebree R, Smith R, Aftab BT, Huang P, Liu JO. Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 619-23. PMID 23546045 DOI: 10.1097/Jto.0B013E31828C3950 |
0.326 |
|
| 2012 |
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, et al. Non-small cell lung cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 1236-71. PMID 23054877 |
0.315 |
|
| 2012 |
Komaki R, Paulus R, Ettinger DS, Videtic GM, Bradley JD, Glisson BS, Langer CJ, Sause WT, Curran WJ, Choy H. Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239. International Journal of Radiation Oncology, Biology, Physics. 83: e531-6. PMID 22560543 DOI: 10.1016/j.ijrobp.2012.01.075 |
0.31 |
|
| 2009 |
Higgins MJ, Ettinger DS. Chemotherapy for lung cancer: The state of the art in 2009 Expert Review of Anticancer Therapy. 9: 1365-1378. PMID 19827996 DOI: 10.1586/ERA.09.115 |
0.341 |
|
| 2009 |
Choy H, Jain AK, Moughan J, Curran W, Whipple G, Demas WF, Ettinger DS. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 4: 80-6. PMID 19096311 DOI: 10.1097/JTO.0b013e318191503f |
0.302 |
|
| 2007 |
Brahmer JR, Ettinger DS. Non-small cell lung cancer: Adjuvant and neo-adjuvant chemotherapy Respirology. 12: 320-325. PMID 17539833 DOI: 10.1111/j.1440-1843.2007.01081.x |
0.305 |
|
| 2005 |
Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4991-8. PMID 15939930 DOI: 10.1200/JCO.2005.00.414 |
0.333 |
|
| 2004 |
Monnerat C, Le Chevalier T, Kelly K, Obasaju CK, Brahmer J, Novello S, Nakamura T, Liepa AM, Bozec L, Bunn PA, Ettinger DS. Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5439-46. PMID 15328182 DOI: 10.1158/1078-0432.CCR-04-0218 |
0.325 |
|
| 2004 |
Ettinger DS. Overview and state of the art in the management of lung cancer Oncology (Williston Park, N.Y.). 18: 3-9. PMID 15255162 |
0.333 |
|
| 2003 |
Spira A, Ettinger DS. Extensive-stage small-cell lung cancer Seminars in Surgical Oncology. 21: 164-175. PMID 14508849 DOI: 10.1002/ssu.10034 |
0.301 |
|
| 2002 |
Ettinger DS. Is there a preferred combination chemotherapy regimen for metastastic non-small cell lung cancer? Oncologist. 7: 226-233. PMID 12065795 DOI: 10.1634/theoncologist.7-3-226 |
0.328 |
|
| 2001 |
Ettinger DS. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer Seminars in Oncology. 28: 27-29. PMID 11479894 |
0.312 |
|
| 1999 |
Ettinger DS. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer Seminars in Radiation Oncology. 9: 148-150. PMID 10210554 |
0.313 |
|
| 1998 |
Ettinger DS. Combined-modality treatment for stage IIIa (N2) non-small cell lung cancer: A National Cancer Institute Intergroup study Cancer Chemotherapy and Pharmacology, Supplement. 42. PMID 9750033 |
0.305 |
|
| 1998 |
Johnson DH, Chang AY, Ettinger DS, Kyung Mann Kim, Bonomi P. Recent advances with chemotherapy for NSCLC: The ECOG experience Oncology. 12: 67-70. PMID 9516615 |
0.313 |
|
| 1998 |
Ettinger DS. The role of carboplatin in the treatment of small-cell lung cancer Oncology. 12: 36-43. PMID 9516610 |
0.336 |
|
| 1998 |
Langer CJ, Ettinger DS. The burgeoning role of paclitaxel in advanced pulmonary malignancy Oncologist. 3: 67-85. |
0.3 |
|
| 1998 |
Brahmer JR, Ettinger DS. Carboplatin in the treatment of small cell lung cancer Oncologist. 3: 143-154. |
0.336 |
|
| 1995 |
Ettinger DS. The place of ifosfamide in chemotherapy of small cell lung cancer: The Eastern Cooperative Oncology Group experience and a selected literature update Seminars in Oncology. 22: 23-27. PMID 7846538 |
0.334 |
|
| 1993 |
Ettinger DS. Overview of paclitaxel (TAXOL®) in advanced lung cancer Seminars in Oncology. 20: 46-49. PMID 8102017 |
0.311 |
|
| 1993 |
Ettinger DS. Taxol in the treatment of lung cancer Journal of the National Cancer Institute. Monographs. 177-179. PMID 7912523 |
0.338 |
|
| 1993 |
Ettinger DS. Metastatic non-small cell lung cancer Lung Cancer. 9: 69-79. DOI: 10.1016/0169-5002(93)90172-T |
0.309 |
|
| 1991 |
Ettinger DS. Evaluation of alternating chemotherapy in patients with small cell lung cancer - a commentary Lung Cancer. 7: 295-298. DOI: 10.1016/0169-5002(91)90025-2 |
0.306 |
|
| Show low-probability matches. |